ALLMedicine™ Prostate-specific Antigen Testing Center

Nov 12th, 2021 - Prostate-Specific Antigen Testing for Prostate Cancer Screening-Is the Message Getting Through?|2021|Hamdy FC,|

Nov 12th, 2021 - In April 2017, the US Preventive Services Task Force (USPSTF) published a draft guideline that reversed its 2012 guidance advising against prostate-specific antigen (PSA)-based screening for prostate cancer in all men (grade D), instead endorsing ...

Aug 20th, 2021 - Recommendations against prostate-specific antigen (PSA) testing in 2012 have increased advanced-stage diagnosis and prostate cancer-specific mortality rates. To present the position of the European Association of Urology (EAU) in 2021 and provide ...

Aug 2nd, 2021 - Patients with disabilities represent a unique minority population. The incidence of prostate-specific antigen (PSA) testing among this population is unknown. To compare PSA testing rates and associated predictors among men with and without reporte...

Jun 26th, 2021 - To investigate the nonlinear relationship between age and the likelihood of undergoing prostate-specific antigen (PSA) testing, and the difference of factors influencing the test likelihood among subjects aged 40-54, 55-69, and ≥70 years. Data wer...

Jun 17th, 2021 - I was in the middle of a clinic visit when one of our nurses knocked on my door. "I'm sorry to interrupt, but your patient's wife just called and really wants to know what his scan showed. " The patient was a man with metastatic lung cancer Like d...

Mar 29th, 2021 - Months of lockdowns throughout 2020 brought mass cancer screening programs to a halt in the United States. Early in the COVID-19 pandemic, the American Cancer Society recommended that "no one should go to a health care facility for routine cancer ...

Dec 5th, 2020 - Neil Fleshner, MD Dutasteride, a 5α-reductase inhibitor approved for the treatment of benign prostatic hyperplasia, may postpone disease progression in men with low-risk prostate cancer who have opted for an active surveillance strategy, as wel...

Dec 5th, 2020 - Leonard G. Gomella, MD During the past year, changes in the diagnosis and treatment of prostate cancer have sparked increased discussion and debate, with many patients and their treating physicians left wondering how to proceed appropriately. ...

Nov 13th, 2020 - Michael J. Morris, MD, Memorial Sloan Kettering Cancer Center, discusses the challenges associated with radium-223 treatment in prostate cancer. In a phase I/IIa clinical trial evaluating the effects of radium-223 with docetaxel versus docetaxel ...